A POINT MUTATION IN THE HUMAN CD45 GENE ASSOCIATED WITH DEFECTIVE SPLICING OF EXON-A

被引:59
作者
THUDE, H [1 ]
HUNDRIESER, J [1 ]
WONIGEIT, K [1 ]
SCHWINZER, R [1 ]
机构
[1] HANNOVER MED SCH,ABDOMINAL & TRANSPLANTAT CHIRURG KLIN,TRANSPLANTAT LAB K25,D-30623 HANNOVER,GERMANY
关键词
CD45RA ISOFORM; VARIANT EXPRESSION; ALTERNATIVE SPLICING; TYROSINE PHOSPHATASE;
D O I
10.1002/eji.1830250745
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD45 is a receptor-type protein tyrosine phosphatase involved in the regulation of lymphocyte activation. Different CD45 isoforms are generated by alternative splicing of three variable exons (A, B and C). The pattern of CD45 splicing depends upon cell type and state of activation. CD45RA isoforms (containing exon A-encoded sequences) can usually be found on a subset of resting T cells, but not on activated T cells. We have recently described a variant pattern of CD45RA expression which is characterized by continuous expression of CD45RA molecules on activated and memory T cells. Here, we demonstrate that this phenotype is associated with heterozygosity for a point mutation at nucleotide position 77 of exon A, leading to a C --> G transition. This mutation does not change the protein sequence of the CD45RA isoform. We conclude that position 77 is part of a motif necessary for splicing of exon A, which supports the hypothesis that sequences within exons have significant effects on alternative splicing. The mutation of this motif might prevent binding of a trans-acting splice factor. In the heterozygous state; this mutation is not associated with impaired T cell reactivity. Functional consequences of the homozygous state remain to be elucidated.
引用
收藏
页码:2101 / 2106
页数:6
相关论文
共 24 条
[1]  
Thomas M.L., Lefrancois L., Immunol. Today, 9, (1988)
[2]  
Streuli M., Hall L.R., Saga Y., Schlossman S.F., Saito H., J. Exp. Med., 166, (1987)
[3]  
Ralph S.J., Thomas M.L., Morton C.C., Trowbridge I.S., EMBO J., 6, (1987)
[4]  
Streuli M., Saito H., EMBO J., 8, (1989)
[5]  
Rothstein D.M., Saito H., Streuli M., Schlossman S.F., Morimoto C., J. Biol. Chem., 267, (1992)
[6]  
Streuli M., Morimoto C., Schrieber M., Schlossman S.F., Saito H., J. Immunol., 141, (1988)
[7]  
Akbar A.N., Terry L., Timms A., Beverley P.C.L., Janossy G., J. Immunol., 140, (1988)
[8]  
Zapata J.M., Pulido R., Acevedo A., Sanchez-Madrid F., de Landazuri M.O., J. Immunol., 152, (1994)
[9]  
Rogers P.R., Pilapil S., Hayakawa K., Romain P.L., Parker D.C., J. Immunol., 148, (1992)
[10]  
Schwinzer R., Wonigeit K., J. Exp. Med., 171, (1990)